Stock-Based Compensation (Tables)

3 Months Ended

Apr. 30, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Compensation Costs

The stock-based compensation costs that have been charged against income were as follows (in thousands):

	13-Weeks Ended
	April 30, 2022		May 1, 2021
Stock-based compensation expense by type:
Stock options	$	155	$	174
Restricted stock units	2,125		1,788
Employee stock purchases	158		85
Director deferred compensation	17		6
Total stock-based compensation expense	2,455		2,053
Income tax benefit recognized	557		479
Stock-based compensation expense, net of income tax	$	1,898	$	1,574

Schedule of Equity Awards Granted

We granted the following equity awards:

	13-Weeks Ended
	April 30, 2022	May 1, 2021
Stock options	7,212	4,384
Restricted stock unit awards	107,848	61,241
Performance-based restricted stock unit awards	49,978	22,492
Deferred stock units	405	84

Schedule of Shares Purchased

The number of shares purchased, the average price per share, and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:

	13-Weeks Ended
	April 30, 2022		May 1, 2021
Shares purchased	14,273		7,445
Average price per share	$	61.14	$	39.25
Weighted-average fair value at grant date	$	18.03	$	11.45